Cardiff Oncology, Inc. (CRDF) NASDAQ
1.58
-0.03(-1.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.58
-0.03(-1.86%)
Currency In USD
| Market Cap | 187.82M |
| Enterprise Value | 171.19M |
| P/E Ratio | -2.3 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 182.15 |
| Price/Book Ratio | 2.33 |
| Enterprise/Revenue | 154.1 |
| Enterprise/EBITDA | -1.96 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -77.32 |
| Operating Margin | -82.56 |
| Return On Assets | -0.74 |
| Return On Equity | -0.82 |
| Revenue | 593,000 |
| Revenue/Share | 0.01 |
| Gross Profit | -311,000 |
| EBITDA | -44.97M |
| Net Income | -45.88M |
| Diluted EPS | -0.69 |
| Total Cash | 58.3M |
| Total Cash/Share | 0.87 |
| Total Debt | 832,000 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 3.67 |
| Book Value Per Share | 0.68 |
| 52-Week Change | -44.95 |
| 52-Week High | 4.56 |
| 52-Week Low | 1.48 |
| Moving Average 50 Days | 1.84 |
| Moving Average 200 Days | 2.42 |
| Average Volume | 1.09M |
| Shares Outstanding | 68.36M |
| % Held by Institutions | 40.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | February 20, 2019 |